Corcept Therapeutics (STU:HTD) Treasury Stock : €-589.8 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Corcept Therapeutics Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Corcept Therapeutics's treasury stock for the quarter that ended in Mar. 2024 was €-589.8 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Corcept Therapeutics Treasury Stock Historical Data

The historical data trend for Corcept Therapeutics's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Treasury Stock Chart

Corcept Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Treasury Stock

Get a 7-Day Free Trial

-56.43

-62.30

-363.21

-430.60

-582.37

Corcept Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Treasury Stock	Get a 7-Day Free Trial															-431.98	-566.79	-591.99	-582.37	-589.77

Corcept Therapeutics Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Corcept Therapeutics (STU:HTD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (STU:HTD) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

CORT:USA HTD:Germany

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.